A random forest-based metabolic risk model to assess the prognosis and metabolism-related drug targets in ovarian cancer.
Comput Biol Med
; 153: 106432, 2023 02.
Article
in En
| MEDLINE
| ID: mdl-36608460
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Random Forest
Type of study:
Clinical_trials
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Comput Biol Med
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: